463.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SNPS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$454.99
Offen:
$450.36
24-Stunden-Volumen:
3.36M
Relative Volume:
2.45
Marktkapitalisierung:
$71.74B
Einnahmen:
$6.22B
Nettoeinkommen (Verlust:
$2.16B
KGV:
33.49
EPS:
13.8535
Netto-Cashflow:
$1.09B
1W Leistung:
-6.99%
1M Leistung:
+0.70%
6M Leistung:
-16.92%
1J Leistung:
-17.84%
Synopsys Inc Stock (SNPS) Company Profile
Firmenname
Synopsys Inc
Sektor
Branche
Telefon
(650) 584-5000
Adresse
675 ALMANOR AVE, SUNNYVALE, CA
Vergleichen Sie SNPS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SNPS
Synopsys Inc
|
463.98 | 77.40B | 6.22B | 2.16B | 1.09B | 13.85 |
![]()
MSFT
Microsoft Corporation
|
460.36 | 3.35T | 270.01B | 96.64B | 69.37B | 12.94 |
![]()
ORCL
Oracle Corp
|
165.53 | 437.38B | 55.78B | 12.16B | 5.81B | 4.26 |
![]()
PLTR
Palantir Technologies Inc
|
131.78 | 291.00B | 3.12B | 570.69M | 1.32B | 0.23 |
![]()
CRWD
Crowdstrike Holdings Inc
|
471.37 | 113.48B | 3.95B | -19.27M | 1.07B | -0.08 |
![]()
FTNT
Fortinet Inc
|
101.78 | 78.96B | 6.14B | 1.88B | 2.07B | 2.43 |
Synopsys Inc Stock (SNPS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-13 | Eingeleitet | Redburn Atlantic | Buy |
2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
2024-11-12 | Eingeleitet | Loop Capital | Buy |
2024-10-22 | Eingeleitet | Mizuho | Outperform |
2024-10-15 | Eingeleitet | Berenberg | Buy |
2024-04-04 | Eingeleitet | Piper Sandler | Overweight |
2023-11-30 | Bestätigt | Needham | Buy |
2023-11-10 | Eingeleitet | Morgan Stanley | Overweight |
2023-09-29 | Eingeleitet | HSBC Securities | Buy |
2022-12-16 | Hochstufung | BofA Securities | Neutral → Buy |
2022-11-16 | Eingeleitet | Edward Jones | Hold |
2022-09-29 | Eingeleitet | Deutsche Bank | Buy |
2022-09-08 | Eingeleitet | Stifel | Buy |
2022-08-17 | Eingeleitet | Wolfe Research | Outperform |
2022-06-29 | Hochstufung | BofA Securities | Underperform → Neutral |
2022-01-10 | Bestätigt | BofA Securities | Underperform |
2021-10-20 | Eingeleitet | Needham | Buy |
2021-09-17 | Herabstufung | BofA Securities | Neutral → Underperform |
2021-09-17 | Fortgesetzt | Rosenblatt | Buy |
2021-06-02 | Eingeleitet | Rosenblatt | Buy |
2021-01-11 | Herabstufung | BofA Securities | Buy → Neutral |
2020-08-20 | Bestätigt | Credit Suisse | Outperform |
2020-08-20 | Bestätigt | KeyBanc Capital Markets | Overweight |
2020-08-20 | Bestätigt | Needham | Buy |
2020-08-20 | Bestätigt | RBC Capital Mkts | Outperform |
2020-08-20 | Bestätigt | Robert W. Baird | Outperform |
2020-08-20 | Bestätigt | Wells Fargo | Overweight |
2020-05-27 | Eingeleitet | UBS | Buy |
2020-02-20 | Bestätigt | Needham | Buy |
2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
2019-09-11 | Fortgesetzt | JP Morgan | Neutral |
2019-08-22 | Bestätigt | Needham | Buy |
2019-05-15 | Eingeleitet | Wells Fargo | Outperform |
2019-04-10 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
2019-04-03 | Bestätigt | Needham | Buy |
2019-03-28 | Bestätigt | Needham | Buy |
2018-12-06 | Bestätigt | Needham | Buy |
2018-12-06 | Hochstufung | The Benchmark Company | Hold → Buy |
2018-11-20 | Eingeleitet | Berenberg | Buy |
2018-10-23 | Hochstufung | JP Morgan | Underweight → Neutral |
Alle ansehen
Synopsys Inc Aktie (SNPS) Neueste Nachrichten
Synopsys: Fundamentally Strong With Limited Upside (NASDAQ:SNPS) - Seeking Alpha
US FTC mandates divestitures in Synopsys-Ansys $35 billion deal - MSN
Stifel Maintains Buy Rating on Synopsys (SNPS) Following Strong Q2 Results - MSN
Synopsys, Inc. (NASDAQ:SNPS) Q2 2025 Earnings Call Transcript - MSN
Synopsys rises after 'clean' Q2 results but export curb speculations loom, mull analysts - MSN
Synopsys (SNPS) Faces Price Target Reduction Amid Regulatory Con - GuruFocus
Synopsys Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Synopsys suspends forecasts after US cracks down on China chip software exports - MSN
Synopsys halts PRC sales due to export restrictions - Taipei Times
U.S. May Tighten China Export Rules on Cadence (CDNS), Synopsys (SNPS) - MSN
Exclusive: Synopsys halts China sales due to US export restrictions, internal memo shows - Reuters
Synopsys suspends sales in China to comply with US export curbsreport - Seeking Alpha
Analysts Are Bullish on These Technology Stocks: SentinelOne (S), Synopsys (SNPS) - The Globe and Mail
Synopsys, Ansys deal may face China delay due to new US export curbs, Berenberg says - TradingView
Chip design software giant pauses China sales and suspends financial guidance — Synopsys slams on the brakes as Washington issues fresh crackdown on semiconductor software exports - Tom's Hardware
FTC Requires Divestitures in USD 35 Billion Synopsys, Ansys Merger - marketscreener.com
Synopsys Blocking Sales in China Amid US Export Restrictions - marketscreener.com
Synopsys (SNPS) Halts Sales in China Amid New U.S. Export Restrictions - GuruFocus
Synopsys Pauses China Sales Amid New Chip Design Export Controls - TipRanks
Synopsys forecasts quarterly revenue largely above estimates - MSN
Synopsys Halts Sales in CN Due to US Chip Export Restrictions: Wire - AASTOCKS.com
Synopsys Suspends Guidance After US Notice on Export Curbs - MSN
Synopsys halts China sales due to US export restrictionsreport By Investing.com - Investing.com Canada
Exclusive-Synopsys halts China sales due to US export restrictions, internal memo shows - MSN
Synopsys (SNPS) Suspends Financial Guidance Amid New Export Rest - GuruFocus
Synopsys (SNPS) Moves Ahead in Ansys Merger After FTC Divestiture Order - Yahoo Finance
FTC will Require Synopsys and ANSYS to Divest Assets to Resolve Merger Concerns - MSN
Synopsys to Report Q2 Earnings: What's in Store for the Stock? - MSN
Chip-design software maker Synopsys suspends guidance after export curbs notice - CNBC TV18
Synopsys (SNPS) Suspends Financial Guidance Amid New Export Restrictions - GuruFocus
Synopsys Stock Gains 4% as Q2 Earnings and Revenues Beat Estimates - MSN
Synopsys Suspends Guidance After Letter About Export Curbs - Bloomberg.com
Synopsys says to forget what it said last night. It did get a government letter about exports to China. - MarketWatch
Synopsys and Cadence Confirm China Export Ban. The Stocks Drop. - Barron's
Uber, Tesla robotaxis, Synopsys guidance: Trending Tickers - Yahoo Finance
Synopsys halts financial guidance amid new China export restrictions - Investing.com
Synopsys (SNPS) and Ansys (ANSS) Told to Trim Deal to Keep $35B Merger Alive - Yahoo
Synopsys (SNPS) Halts Guidance After BIS China Export Notice - MSN
Synopsys (SNPS) Maintains 'Buy' Rating with $650 Target by Needh - GuruFocus
Synopsys says to forget what it said last night. It did get a BIS letter about exports to China. - MarketWatch
Rosenblatt Adjusts Price Target for Synopsys (SNPS) Amidst Marke - GuruFocus
Synopsys (SNPS) Price Target Raised by BofA Analyst Despite Chin - GuruFocus
Synopsys (SNPS) Stock Moves on FTC Approval for Ansys Acquisition - GuruFocus
Synopsys suspends Q3, full-year guidance after China export controls surface - MSN
Here's Why Shares in Synopsys Popped Higher Today - Yahoo Finance
Synopsys suspends Q3, full-year guidance after China export controls surface (SNPS:NASDAQ) - Seeking Alpha
Synopsys Confirms China Export Ban. The Stock Drops. - MSN
Synopsys suspends forecasts after US cracks down on China chip software exports By Reuters - Investing.com
Finanzdaten der Synopsys Inc-Aktie (SNPS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Synopsys Inc-Aktie (SNPS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
RUNKEL JOHN F JR | GC & Corporate Secretary |
Mar 15 '25 |
Option Exercise |
0.00 |
406 |
0 |
23,534 |
MAHONEY RICHARD S. | Chief Revenue Officer |
Mar 15 '25 |
Option Exercise |
0.00 |
794 |
0 |
2,279 |
Glaser Shelagh | CFO |
Mar 15 '25 |
Option Exercise |
0.00 |
794 |
0 |
15,572 |
Ghazi Sassine | PRESIDENT AND CEO |
Mar 15 '25 |
Option Exercise |
0.00 |
1,323 |
0 |
72,245 |
DE GEUS AART | EXECUTIVE CHAIR |
Mar 15 '25 |
Option Exercise |
0.00 |
1,764 |
0 |
118,435 |
DE GEUS AART | EXECUTIVE CHAIR |
Mar 06 '25 |
Option Exercise |
89.76 |
15,705 |
1,409,681 |
132,376 |
DE GEUS AART | EXECUTIVE CHAIR |
Mar 06 '25 |
Sale |
444.42 |
15,705 |
6,979,652 |
116,671 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):